Effectiveness of Exercise Alone and tDCS+Exercise on Cognitive Function Improvement in Patients With Treatment Resistant Schizophrenia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorKit Wa Chan

About this trial

Cognitive impairment is a major determinant of disability in schizophrenia. Aerobic exercise improves global cognition in schizophrenia, particularly working memory and attention/vigilance. Transcranial direct current stimulation (tDCS) targeting frontal regions has shown promise for cognitive deficits, including working memory improvements in some studies. This randomized 2×2 factorial trial will test the independent and combined effects of supervised aerobic exercise and prefrontal tDCS on cognition in treatment resistant schizophrenia, measured using the MATRICS Consensus Cognitive Battery (MCCB).

Eligibility criteria

Qualifiers

DSM 5 schizophrenia-spectrum disorders

Treatment resistant schizophrenia: inadequate response to ≥2 antipsychotics of adequate dose/duration

Clinically stable ≥4 weeks

Able to provide informed consent

Disqualifiers

Neurological disorder (e.g., epilepsy, stroke) or significant head injury

Implanted electronic devices / contraindications to tDCS; scalp lesions at electrode sites

Medical contraindications to moderate aerobic exercise

Substance dependence within 3 months (except nicotine)

Trial design

Treatments tested in this trial

  • Aerobic Exercise
  • Stretching/Education Control
  • Active tDCS
  • Sham tDCS

Treatment groups

160 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Kit Wa Chan

Lead sponsor

The University of Hong Kong

Sponsor institution